Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients [letter] NLM AIDSLINE Important note: Information in this article was accurate in 1994. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Four different regimens for prevention of Pneumocystis carinii pneumonia and toxoplasma encephalitis in HIV-infected patients [letter]

AIDS. 1994 Feb;8(2):272-4. Unique Identifier : AIDSLINE MED/94318217
Tocchetti A; Tambini R; Allegro A; Longoni E; Rinaldi E


Keywords: Adult AIDS-Related Opportunistic Infections/*PREVENTION & CONTROL Comparative Study Dapsone/ADMINISTRATION & DOSAGE/ADVERSE EFFECTS/*THERAPEUTIC USE Drug Therapy, Combination Female Follow-Up Studies Human Male Pentamidine/ADMINISTRATION & DOSAGE/ADVERSE EFFECTS/*THERAPEUTIC USE Pneumonia, Pneumocystis carinii/*PREVENTION & CONTROL Pyrimethamine/ADMINISTRATION & DOSAGE/ADVERSE EFFECTS/ *THERAPEUTIC USE Sulfalene/ADMINISTRATION & DOSAGE/ADVERSE EFFECTS/*THERAPEUTIC USE Toxoplasmosis, Cerebral/*PREVENTION & CONTROL Treatment Outcome Trimethoprim-Sulfamethoxazole Combination/ADVERSE EFFECTS/ *THERAPEUTIC USE CLINICAL TRIAL LETTER RANDOMIZED CONTROLLED TRIAL JOURNAL ARTICLE

KWDadultaids-relatedopportunisticinfections/KWDprevention&controlcomparativestudydapsone/administration&dosage/adverseeffects/KWDtherapeuticusedrugtherapy,combinationfemalefollow-upstudieshumanmalepentamidine/administration&dosage/adverseeffects/KWDtherapeuticusepneumonia,pneumocystiscarinii/KWDprevention&controlpyrimethamine/administration&dosage/adverseeffects/KWDtherapeuticusesulfalene/administration&dosage/adverseeffects/KWDtherapeuticusetoxoplasmosis,cerebral/KWDprevention&controltreatmentoutcometrimethoprim-sulfamethoxazolecombination/adverseeffects/KWDtherapeuticuseclinicaltrialletterrandomizedcontrolledtrialjournalarticle
941130
M94B0762


Copyright © 1994 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1994. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1994. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .